|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07D 413/14 | (2006.01) |
| A61K 31/497 | (2006.01) | ||
| A61K 31/535 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 37/00 | (2006.01) | ||
| A61P 11/00 | (2006.01) | ||
| A61P 31/12 | (2006.01) |
| (11) | Number of the document | 2899191 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14194866.1 |
| Date of filing the European patent application | 2010-04-28 | |
| (97) | Date of publication of the European application | 2015-07-29 |
| (45) | Date of publication and mention of the grant of the patent | 2017-08-09 |
| (46) | Date of publication of the claims translation | 2017-10-25 |
| (30) | Number | Date | Country code |
| 174033 P | 2009-04-30 | US |
| (72) |
Hamblin, Julie Nicole, GB
Jones, Paul Spencer, GB
Keeling, Suzanne Elaine, GB
Le, Joelle, GB
Mitchell, Charlotte Jane, GB
Parr, Nigel James, GB
|
| (73) |
Glaxo Group Limited,
980 Great West Road, Brentford, Middlesex TW8 9GS,
GB
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Oksazolo pakeistieji indazolai kaip PI3-kinazės inhibitoriai |
| OXAZOLE SUBSTITUTED INDAZOLES AS PI3-KINASE INHIBITORS |
| Payment date | Validity (years) | Amount | |
| 2020-04-07 | 11 | 289.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2021-04-28 |